2,4-Methylated Diphosphite Ligands for Hydroformylation Selectivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing hydroformylation processes using traditional phosphorus-containing ligands suffer from low n/iso-selectivity in producing aldehydes, which limits the efficiency and specificity of the reaction.

Innovation Solution

Development of diphosphites with specific 2,4-methylated wing building blocks as ligands, specifically compounds with structures (I) and (1), which form ligand-metal complexes with Rh, Ru, Co, or Ir catalysts to enhance the hydroformylation of olefins, allowing for increased n/iso-selectivity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If traditional phosphorus-containing ligands are used in hydroformylation, then the reaction can proceed, but the n/iso-selectivity is low

Engineering Contradiction:
Improven/iso-selectivityVSAvoidligand structure complexity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent applies local quality by introducing specific 2,4-methylated building blocks with defined stereochemistry at particular positions of the ligand structure. The open and closed wing building blocks contain specific methyl group arrangements that locally enhance n/iso-selectivity without requiring complete structural redesign of the entire ligand system

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent changes structural parameters of the ligand by varying the substitution patterns (2,4-methylation), stereochemical configurations (R/S designations), and building block types (open vs closed wings). These parameter changes systematically improve n/iso-selectivity while maintaining ligand feasibility for synthesis and catalyst formation

Inventive Principle:
Principle #35Parameter changes

2Ease of manufacture

If ligand structure is simplified for easier manufacture, then ease of manufacture improves, but n/iso-selectivity decreases

Engineering Contradiction:
Improveligand synthesis easeVSAvoidn/iso-selectivity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent segments the ligand into modular building blocks (open wing and closed wing components) that can be synthesized independently and then assembled. This segmentation allows each module to be optimized for both synthetic accessibility and functional performance, achieving high n/iso-selectivity without excessive overall complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates composite ligand structures by combining different building block types (open wing with closed wing, various 2,4-methylated variants). These composite structures achieve superior n/iso-selectivity by integrating complementary features from each component while remaining synthetically tractable through modular assembly

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The new ligands significantly improve n/iso-selectivity in hydroformylation reactions, achieving higher linear to branched aldehyde ratios compared to traditional ligands, as demonstrated by catalysis experiments with n-octene, showing a 77% n/iso selectivity versus 56% with comparative ligands.

Implementation Method 1

the reactions between olefin compounds, carbon monoxide and hydrogen in the presence of a catalyst to produce aldehydes that are one carbon atom richer is known as hydroformylation or oxidation. Compounds of the transition metals of Group VIII of the Periodic Table of Elements are often used as catalysts in these reactions

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP4074721B1Diphosphites having one open and one closed 2,4-methylated building block
Publication Date: 2023.10.04 EVONIK OXENO GMBH & CO KG
  • EP4074721B1 patent drawing
  • EP4074721B1 patent drawing
  • EP4074721B1 patent drawing

AI summary

Diphosphites with an open and a closed 2,4-methylated wing component and their use in hydroformylation.